PT001 MDI versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Trial Identifier: PT001002
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT01350128
Start Date: May 2011
Primary Completion Date: October 2011
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
USA, Florida Panama City, Florida, USA
USA, Florida Winter Park, Florida, USA
USA, New Jersey Cherry Hill, New Jersey, USA
USA, New Jersey Summit, New Jersey, USA
USA, North Carolina Charlotte, North Carolina, USA
USA, Oregon Medford, Oregon, USA
USA, Texas Longview, Texas, USA
USA, Virginia Richmond, Virginia, USA